Newborns are at high risk for severe complications from pertussis, which can lead to pneumonia, convulsions, and even death. Since infants cannot receive the TDAP vaccine until they are at least 2 months old, they rely on maternal antibodies for protection during the early months of life. Vaccinating pregnant women with the TDAP vaccine allows for the transfer of these protective antibodies to the baby before birth.
